English
Supriya Lifescience Q3 Results
- BSE: 543434
- NSE: SUPRIYA
- ISIN: INE07RO01027
- Sector: Biotechnology & Drugs
BSE
714.45
-34.60 (-4.62%)
-34.60 (-4.62%)Volume6.56 K
Updated: Fri 23 Jan, 2026 | 15:28:00
NSE
716.05-31.25 (-4.18%)
-31.25 (-4.18%)Volume1.13 L
Updated: Fri 23 Jan, 2026 | 15:40:15
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q3 Results Highlights
Quarter ended Dec 24
Note: Comparison is on QoQ basis
Quarterly - Supriya Lifescience Q3 Results
*All figures in crores except per share values
| Fiscal Period | Dec 24 | Sep 24 | QoQ Comp | Dec 23 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 124.66 | 106.13 | 17.46% | 102.55 | 21.57% |
| Depreciation/ Amortization | 4.96 | 4.74 | 4.64% | 3.96 | 25.35% |
| Operating Income | 60.99 | 59.97 | 1.69% | 37.53 | 62.51% |
| Net Income | 46.78 | 46.15 | 1.37% | 29.79 | 57.06% |
| Other Operating Expenses Total | 38.14 | 35.73 | 6.77% | 26.40 | 44.48% |
| Net Income Before Taxes | 62.58 | 62.06 | 0.83% | 40.10 | 56.06% |
| Total Revenue | 185.65 | 166.10 | 11.77% | 140.07 | 32.54% |
| Selling/ General/ Admin Expenses Total | 19.77 | 19.69 | 0.44% | 17.56 | 12.57% |
| Diluted Normalized EPS | 5.82 | 5.71 | 1.93% | 3.70 | 57.30% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.